Giovinazzo Francesco, Avolio Alfonso W, Galiandro Federica, Vitale Alessandro, Dalla Riva Giulio V, Biancofiore Gianni, Sharma Shivani, Muiesan Paolo, Agnes Salvatore, Burra Patrizia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Transplant Direct. 2021 Feb 11;7(3):e669. doi: 10.1097/TXD.0000000000001115. eCollection 2021 Mar.
Solid organ transplants (SOTs) are life-saving interventions, recently challenged by coronavirus disease 2019 (COVID-19). SOTs require a multistep process, which can be affected by COVID-19 at several phases.
SOT-specialists, COVID-19-specialists, and medical ethicists designed an international survey according to CHERRIES guidelines. Personal opinions about continuing SOTs, safe managing of donors and recipients, as well as equity of resources' allocation were investigated. The survey was sent by e-mail. Multiple approaches were used (corresponding authors from Scopus, websites of scientific societies, COVID-19 webinars). After the descriptive analysis, univariate and multivariate ordinal regression analysis was performed.
There were 1819 complete answers from 71 countries. The response rate was 49%. Data were stratified according to region, macrospecialty, and organ of interest. Answers were analyzed using univariate-multivariate ordinal regression analysis and thematic analysis. Overall, 20% of the responders thought SOTs should not stop (continue transplant without restriction); over 70% suggested SOTs should selectively stop, and almost 10% indicated they should completely stop. Furthermore, 82% agreed to shift resources from transplant to COVID-19 temporarily. Briefly, main reason for not stopping was that if the transplant will not proceed, the organ will be wasted. Focusing on SOT from living donors, 61% stated that activity should be restricted only to "urgent" cases. At the multivariate analysis, factors identified in favor of continuing transplant were Italy, ethicist, partially disagreeing on the equity question, a high number of COVID-19-related deaths on the day of the answer, a high IHDI country. Factors predicting to stop SOTs were Europe except-Italy, public university hospital, and strongly agreeing on the equity question.
In conclusion, the majority of responders suggested that transplant activity should be continued through the implementation of isolation measures and the adoption of the COVID-19-free pathways. Differences between professional categories are less strong than supposed.
实体器官移植(SOTs)是挽救生命的干预措施,最近受到2019冠状病毒病(COVID-19)的挑战。SOTs需要一个多步骤过程,这在几个阶段都可能受到COVID-19的影响。
SOT专家、COVID-19专家和医学伦理学家根据CHERRIES指南设计了一项国际调查。调查了关于继续进行SOTs、安全管理供体和受体以及资源分配公平性的个人意见。该调查通过电子邮件发送。采用了多种方法(来自Scopus的通讯作者、科学协会网站、COVID-19网络研讨会)。在进行描述性分析后,进行了单变量和多变量有序回归分析。
来自71个国家的1819份完整答案。回复率为49%。数据根据地区、宏观专业和感兴趣的器官进行分层。使用单变量-多变量有序回归分析和主题分析对答案进行分析。总体而言,20%的受访者认为SOTs不应停止(无限制地继续移植);超过70%的人建议SOTs应选择性停止,近10%的人表示应完全停止。此外,82%的人同意暂时将资源从移植转向COVID-19。简而言之,不停止的主要原因是如果移植不进行,器官将被浪费。关注活体供体的SOT,61%的人表示活动应仅限制在“紧急”病例。在多变量分析中,确定有利于继续移植的因素是意大利、伦理学家、部分不同意公平问题、回答当天COVID-19相关死亡人数较多、人类发展指数较高的国家。预测停止SOTs的因素是除意大利外的欧洲、公立大学医院以及强烈同意公平问题。
总之,大多数受访者建议通过实施隔离措施和采用无COVID-19途径来继续移植活动。专业类别之间的差异没有想象的那么大。